Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2020-04-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a formal statement from the company's board nominating an independent director candidate. It includes detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report summaries. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2020-04-08 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, earnings information, or report content. The document is an announcement related to board/management changes, specifically about the nomination of a board member. Therefore, it fits the category of Board/Management Information (MANG). The document length and content support this classification with high confidence.
2020-04-08 Chinese
关于使用部分闲置募集资金购买的理财产品到期赎回并继续进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 启迪古汉集团股份有限公司 regarding the redemption of financial products purchased with idle raised funds and the continuation of cash management activities. It details specific transactions, amounts, dates, and risk control measures related to the use of idle raised funds for purchasing financial products such as large certificates of deposit. The document references prior board and shareholder approvals and includes detailed tables of past transactions. It is not a full financial report, earnings release, or management discussion but rather an update on capital management activities related to raised funds. The document is a formal announcement about the company's capital/financing activities, specifically the use and management of idle raised funds, which fits the category of Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about financing activities, not merely a notice or certification, so it is not RPA or RNS.
2020-03-31 Chinese
2019年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2019 annual performance forecast (业绩预告) for the company, providing estimated net profit and earnings per share for the full year 2019. It explicitly states that the financial data is preliminary and unaudited, and that the final official financial data will be disclosed in the formal 2019 annual report. The document is short (685 characters) and serves as an earnings forecast rather than a full financial report. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only, not the full annual report (10-K). FY 2019
2020-01-20 Chinese
关于控股股东开展融资融券业务的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (521 characters) regarding the controlling shareholder engaging in margin financing and securities lending activities. It details the number of shares involved and confirms that ownership has not changed. There is no financial report, no detailed financial data, no management discussion, or earnings information. The document is an announcement about financing activities related to shareholding, specifically about the controlling shareholder's margin financing business. This fits the category of Capital/Financing Update (CAP).
2019-12-30 Chinese
关于使用部分闲置募集资金购买的理财产品到期赎回并继续进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the use of idle raised funds to purchase financial products, their maturity, redemption, and continued cash management activities. It includes specific investment amounts, dates, yields, and risk control measures. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is a regulatory disclosure about capital management activities related to fundraising proceeds. This fits best under Capital/Financing Update (CAP) as it updates on the company's use of raised funds and cash management activities.
2019-12-27 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.